Autoantibodies to gangliosides in sera of atherosclerotic patients

Clinica Chimica Acta

Volumn 272, Issue 2, 1998, Pages 197-207

  Golovanova, Natalia K ^a   Gracheva, Elena V ^a   Basharova, Lubov A ^a   Kozlov, Sergei G ^a   Lyakishev, Anatoliy A ^a   Prokazova, Nina V ^a   Bergelson, Lev D ^a,b  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Atherosclerosis; Autoantibodies; Ganglioside GM3; Serotonin

Indexed keywords

AUTOANTIBODY; GANGLIOSIDE; GANGLIOSIDE GM1; GANGLIOSIDE GM2; GANGLIOSIDE GM3; SEROTONIN; SIALIC ACID;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; ANTIGEN-ANTIBODY REACTIONS; ARTERIOSCLEROSIS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; G(M3) GANGLIOSIDE; HUMANS; MALE; MIDDLE AGED; SEROTONIN;

EID: 0032571748     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(98)00013-8     Document Type: Article

References (32)

1. [1] Bergelson LD, Prokazova NV. Gangliosides and atherosclerosis. Lipids 1994;29:1-5.
2. [2] DeClerck F, van Nueten JM, Reneman RS. Platelet-vessel wall interactions: implications of 5-hydroxytryptamine. A review. Agents Actions 1984;15:612-31.
3. [3] Breckenridge WC. Structural characterization of gangliosides from normal and atherosclerotic human thoratic aortas. Adv Exp Med Biol 1977;82:164-8.
4. [4] Prokazova NV, Orekhov AN, Mukhin DN, Milkailenko IA, Kogtev LS, Sadovskaya VL, Golovanova NK, Bergelson LD. The gangliosides of adult human aorta: intima, media and plaque. Eur J Biochem 1987;67:349-52.
5. [5] Mikhailenko IA, Dubrovskaya SA, Korepanova OB, Morozkin AD, Prokazova NV, Bergelson LD. Interaction of low density lipoproteins with gangliosides. Biochim Biophys Acta 1991;1085:299-305.
6. [6] Prokazova NV, Mikhailenko IA, Bergelson LD. Ganglioside GM3 stimulates the uptake and processing of low-density lipoproteins by macrophages. Biochem Biophys Res Comm 1991;177:582-7.
7. [7] Mazurov AV, Prokazova NV, Mikhailenko IA, Mukhin DN, Repin VS, Bergelson LD. Stimulation of platelet adhesion and activation by ganglioside GD3. Biochim Biophys Acta 1988;968:167-71.
8. [8] Wick G, Schett O, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease?. Immunol Today 1995;26:27-33.
9. [9] Dyatlovitzkaya EV, Koroleva AB, Suskova VS, Rozynov BV, Bergelson LD. Influence of ganglioside GM3 and its breakdown products on lymphoblastic transformation and T-suppressor activity. Eur J Biochem 1991;199:643-96.
10. [10] Dyatlovitskaya EV. Glycosphingolipids. In: Bergelson LD, editor. Lipid biochemical preparations. Amsterdam: Elsevier/North Holland Biochemical Press, 1980:244.
11. [11] Ledeen RW, Yu RK. Gangliosides: structure, isolation and analysis. Methods Enzymol 1982;83:139-91.
12. [12] Svennerholm L. Sialic acid and derivatives. Estimation by ion-exchange method. Methods Enzymol 1963;6:458-62.
13. [13] Jourdian GW, Dean L, Roseman S. The sialic acids. IX. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J Biol Chem 1971;246:430-5.
14. [14] Marcus DM, Latov N, Hsi BF, Gillard BP. Measurement and significance of antibodies against GM1. J Neuroimmunol 1989;25:255-9.
15. [15] Basharova LA, Evseev VA, Vetrile LA. Induction of autoantibodies to serotonin and catecholamines in chronically morphinized rats displaying withdrawal syndrome. Byull Eksp Biol Med (Russia) 1993;5:469-71.
16. [16] Lindberg O, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson B. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993;103:123-9.
17. [17] Tertov VV, Orekhov AN, Sobenin IA, Morriset JD, Gotto AM, Guevara JGJ. Carbohydrate composition of protein and lipid components in sialic acid-rich and poor low density lipoproteins from subjects with and without coronary artery disease. J Lipid Res 1993;34:365-75.
18. [18] Senn HJ, Orth M, Fitzke E, Koester W, Wieland H, Gerock W. Human serum gangliosides in hypercholesterolemia before and after extracorporal elimination of LDL. Atherosclerosis 1992;94:109-17.
19. [19] Ashwell C, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 1975;41:99-128.
20. [20] Bobryshev YV, Lord RSA, Golovanova NK, Gracheva EV, Zvezdina ND, Sadovskaya VL, Prokazova NV. Incorporation and localisation of ganglioside GM3 in human intimal atherosclerotic lesions. Biochim Biophys Acta 1997;1361:287-94.
21. [21] Itonori S, Hidari K, Sanay Y, Tanguchi M, Nagai Y. Involvement of the acyl chain of ceramide in carbohydrate recognition by an antiglycolipid monoclonal antibody: the case of an anti-melanoma antibody M 2590 to GM3-ganglioside. Glycoconjugate J 1989;6:551-60.
22. [22] Marcus AJ, Ullman HL, Safier LB. Studies on human platelet gangliosides. J Clin Invest 1972;51:2602-12.
23. [23] Hegle RA. The pathogenesis of atherosclerosis. Clin Chim Acta 1996;246:21-38.
24. [24] Chatterjee D, Anderson GM. The human platelet dense granule: Serotonin uptake, tetrabenazine binding, phospholipid and ganglioside profiles. Arch Biochem Biophys 1993;1302:430-46.
25. +2 mobilization and functional responses in human platelets. Glycobiology 1996;6:347-53.
26. [26] Vasylevskay VV, Zvezdina ND, Korotaeva AA, Prokazova NV. The influence of gangliosides on serotonin binding and uptake by human platelets. Platelets 1995;6:37-42.
27. [27] Bergelson LD. Serum gangliosides as endogenous immunomodulators. Immunol Today 1995;16:483-6.
28. [28] Hakomori S-I. Tumor-associated glycolipid antigens. Chem Phys Lipids 1986;42:209-33.
29. [29] Misasi R, Sorice M, Griggi T, D'Agostino F, Garofalo T, Masala C, Pontieri GM, Lenti L. GM3 as target of anti-lymphocytic ganglioside antibodies in AIDS patients. Clin Immunol Immunopathol 1993;67:216-23.
30. [30] Saito M. Bioactive sialoglycosphingolipids (gangliosides). Develop Growth Differ 1989;31:509-22.
31. [31] Hakomori S-I. Bifunctional role of glycosphingolipids. J Biol Chem 1990;265:18713-6.
32. [32] Rebbaa A, Hurh J, Yamamoto H, Kersey DS, Bremer EG. Ganglioside GM3 inhibition of EGF receptor mediated signal transduction. Glycobiology 1996;6:399-406.